CDMO Services for Finished Dosage Forms (FDF): Formulation, Development, and Manufacturing

What are CDMO Services?

CDMO services cover the outsourced development and manufacture of pharmaceutical products by handling tasks such as formulation development, analytical testing, clinical trial material production, commercial manufacturing, and packaging. For FDFs, such as tablets, capsules, and injectables, CDMOs offer end-to-end support from concept to market.

Navigating CDMO Outsourcing

A practical guide.
article

The Role of CDMOs in Finished Dosage Form Development

CDMOs bring technical expertise, infrastructure, and regulatory knowledge to FDF development. They help you:

  • Translate active pharmaceutical ingredients (APIs) into stable, effective dosage forms
  • Optimise formulations for bioavailability, stability, and manufacturability
  • Conduct analytical and stability testing
  • Prepare documentation for regulatory submissions

FDF Formulation Services Offered by CDMOs

Formulation is a critical phase in FDF development. CDMOs offer:

  • Pre-formulation studies: Assessing API properties to guide formulation strategy
  • Formulation development: Creating prototypes for oral solids, liquids, injectables, and more
  • Excipient compatibility testing: Ensuring stability and performance
  • Process development: Designing scalable, reproducible manufacturing processes

Scale-Up and Manufacturing Support for FDFs

Once a formulation is finalised, CDMOs support scale-up and commercial manufacturing. This includes:

  • Technology transfer: Moving lab-scale processes to pilot or commercial scale
  • GMP manufacturing: Producing clinical and commercial batches in compliance with regulatory standards
  • Packaging and labelling: Customised to market and regulatory needs
  • Supply chain management: Ensuring timely delivery and inventory control

The Importance of a CDMO

Your essential guide to pharmaceutical CDMOs
article

Regulatory Compliance and Quality Assurance in CDMO Partnerships

  • Regulatory strategy support: Helping you navigate global requirements
  • Documentation and dossier preparation: For IND, NDA, ANDA, and MAA submissions
  • Quality assurance systems: Covering GMP, data integrity, and audit readiness
  • Ongoing compliance monitoring: Through internal audits and continuous improvement

Choosing the Right CDMO for Your Finished Dosage Form Project

When selecting a CDMO, consider:

  • Technical capabilities: Do they have experience with your dosage form and therapeutic area?
  • Regulatory track record: Have they supported successful submissions in your target markets?
  • Scalability: Can they support your product from clinical to commercial scale?

Conclusion

CDMO services for Finished Dosage Forms offer a streamlined path from formulation to market. By leveraging their expertise, infrastructure, and regulatory knowledge, you can reduce risk, improve efficiency, and bring high-quality products to patients faster. Choosing the right CDMO is a strategic decision that can significantly impact your product’s success.

Let's work together

How can we help you?

Speak with our experts and discover how we can support your drug program goals.

Frequently Asked Questions

CDMOs work with a wide range of dosage forms including tablets, capsules, liquids, injectables, and topical formulations.

Yes. Many CDMOs offer integrated services from early-stage development through to full-scale commercial production.

They maintain GMP-certified facilities, follow ICH guidelines, and support regulatory submissions with validated data and documentation.

Outsourcing reduces capital investment, accelerates timelines, and gives you access to specialised expertise and infrastructure.

Download our Brochure.

If you’re looking to work with a CDMO that can support your product from pre-clinical development to market, then we’re here to help.
Download our brochure to learn more about our capabilities.

Let's Talk.

Book a discovery call.

Speak with our team of experts and set up a discovery call to discuss your project in more detail.